Press Releases - 2021-12-15

Date	Title	Company
15-Dec-2021	Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing	Depixus
15-Dec-2021	Abzena Promotes Troy Wright to Senior Vice President and Global Head of Quality	Abzena
15-Dec-2021	GW Pharmaceuticals receives approval for the reimbursement of Epidyolex® (cannabidiol) for the treatment of seizures associated with Tuberous sclerosis complex in Wales	GW Pharmaceuticals
15-Dec-2021	Sareum receives ‘Intention to Grant’ Notification from the European Patent Office for its TYK2/JAK1 inhibitor SDC-1802	Sareum
15-Dec-2021	Transgene announces License Option Exercise by AstraZeneca for an Oncolytic Virus Generated by Transgene’s Invir.IO™ Platform	Transgene
15-Dec-2021	Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation	Sanofi and GSK
15-Dec-2021	Bionaut Labs and Candel Therapeutics Announce Strategic Collaboration in Precision-Targeted Delivery of Oncolytic Viral Immunotherapies	Bionaut Labs
15-Dec-2021	Carterra and PerkinElmer Sign Distribution Agreement For Asia-Pacific and Oceania Region for Carterra’s High Throughput Antibody Screening and Characterization Solutions	Carterra
15-Dec-2021	Freeline Announces 2022 Corporate Priorities and Guidance	Freeline
15-Dec-2021	OKYO Pharma announces issuance of U.S. Patent No. 11,197,906 covering OKYO Pharma’s drug candidate OK-101 for use to treat dry eye disease	OKYO Pharma
15-Dec-2021	HUTCHMED Highlights HMPL-523 Clinical Data Presented at the 2021 ASH Annual Meeting	HUTCHMED
15-Dec-2021	CSL Limited announces tender offer to acquire Vifor Pharma Ltd	CSL Limited
15-Dec-2021	Ichnos Sciences and Almirall Enter into a Licensing Agreement for First-in-Class IL-1RAP Antagonist Monoclonal Antibody	Ichnos Sciences
15-Dec-2021	YESCARTA® (AXICABTAGENE CILOLEUCEL) ZUMA-12 STUDY DEMONSTRATES 78% COMPLETE RESPONSE RATE AS PART OF FIRST-LINE TREATMENT IN NEWLY DIAGNOSED HIGH-RISK LARGE B CELL LYMPHOMA	Kite, a Gilead Company
15-Dec-2021	Globus Group protects NHS frontline workers across the UK with pioneering new UK-made transparent face mask	Globus Group
15-Dec-2021	Actimed Therapeutics Achieves Major Corporate Milestone - Initiation of first clinical study of new salt of S-pindolol (ACM-001.1)	Actimed Therapeutics
15-Dec-2021	The FDA Goes Live with LifeSphere MultiVigilance, Modernizing Pharmacovigilance Capabilities with FAERS II	ArisGlobal
15-Dec-2021	Increasing reliance on last resort antibiotics reveals worrying superbug trend among LMICs – new data published in Lancet Global Health	University of KwaZulu-Natal
15-Dec-2021	A medication against SARS-CoV-2	Technical University of Munich (TUM),
15-Dec-2021	Bachem begins building its biggest ever production facility as Switzerland celebrates National Future Day	Bachem